{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:15:28Z","timestamp":1788984928777,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jclinepi.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jclinepi.2026.112415","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:40:17Z","timestamp":1783698017000},"page":"112415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The importance of adequate user feedback for developing appraisal tools for evidence synthesis\u2013the case of TACIT (Tool for Addressing Conflicts of Interest in Trials)"],"prefix":"10.1016","volume":"198","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4982-8680","authenticated-orcid":false,"given":"Andreas","family":"Lundh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Boutron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley A.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asbj\u00f8rn","family":"Hr\u00f3bjartsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jclinepi.2026.112415_bib1","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.5","article-title":"Chapter I: introduction","author":"Cumpston","year":"2024"},{"key":"10.1016\/j.jclinepi.2026.112415_bib2","series-title":"Finding What Works in Health Care: Standards for Systematic Reviews","article-title":"Committee on standards for systematic reviews of comparative effectiveness research","year":"2011"},{"key":"10.1016\/j.jclinepi.2026.112415_bib3","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2026.112415_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081199","article-title":"Development of ROBUST-RCT: risk of Bias instrument for Use in SysTematic reviews-for Randomised Controlled Trials","volume":"388","author":"Wang","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2026.112415_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076754","article-title":"ROB-ME: a tool for assessing risk of bias due to missing evidence in systematic reviews with meta-analysis","volume":"383","author":"Page","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2026.112415_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-084164","article-title":"Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions","volume":"14","author":"Wilkinson","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.jclinepi.2026.112415_bib7","article-title":"INSPECT-SR: a tool for assessing trustworthiness of randomised controlled trials","author":"Wilkinson","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/j.jclinepi.2026.112415_bib8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13643-017-0604-6","article-title":"A proposed framework for developing quality assessment tools","volume":"6","author":"Whiting","year":"2017","journal-title":"Syst Rev"},{"key":"10.1016\/j.jclinepi.2026.112415_bib9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jclinepi.2019.12.005","article-title":"Systematic review finds that appraisal tools for medical research studies address conflicts of interest superficially","volume":"120","author":"Lundh","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2026.112415_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-015997","article-title":"Characteristics of funding of clinical trials: cross-sectional survey and proposed guidance","volume":"7","author":"Hakoum","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jclinepi.2026.112415_bib11","article-title":"Financial ties of principal investigators and randomized controlled trial outcomes: cross sectional study","volume":"356","author":"Ahn","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2026.112415_bib12","series-title":"Conflict of Interest in Medical Research, Education, and Practice","article-title":"Committee on conflict of interest in medical research, education, and practice","year":"2009"},{"key":"10.1016\/j.jclinepi.2026.112415_bib13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jclinepi.2017.04.002","article-title":"Authors of clinical trials reported individual and financial conflicts of interest more frequently than institutional and nonfinancial ones: a methodological survey","volume":"87","author":"Hakoum","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2026.112415_bib14","article-title":"Collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of lead academic authors","volume":"363","author":"Rasmussen","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2026.112415_bib15","first-page":"MR000033","article-title":"Industry sponsorship and research outcome","volume":"2","author":"Lundh","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jclinepi.2026.112415_bib16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/jrsm.1527","article-title":"Combining meta-epidemiological study datasets on commercial funding of randomised clinical trials: database, methods, and descriptive results of the COMFIT study","volume":"13","author":"Nejstgaard","year":"2022","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.jclinepi.2026.112415_bib17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/jrsm.1611","article-title":"Commercial funding and estimated intervention effects in randomized clinical trials: systematic review of meta-epidemiological studies","volume":"14","author":"Nejstgaard","year":"2023","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.jclinepi.2026.112415_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081477","article-title":"SPIRIT 2025 statement: updated guideline for protocols of randomised trials","volume":"389","author":"Chan","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2026.112415_bib20","article-title":"CONSORT 2025 statement: updated guideline for reporting randomised trials","volume":"389","author":"Hopewell","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2026.112415_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/bmjebm-2019-111230","article-title":"What to do with a clinical trial with conflicts of interest","volume":"25","author":"Lundh","year":"2020","journal-title":"BMJ Evid Based Med"},{"key":"10.1016\/j.jclinepi.2026.112415_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-035633","article-title":"Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study","volume":"10","author":"Turner","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.jclinepi.2026.112415_bib24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13643-016-0259-8","article-title":"Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews","volume":"5","author":"J\u00f8rgensen","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.jclinepi.2026.112415_bib25","first-page":"1","article-title":"Tool for Addressing Conflicts of Interest in Trials (TACIT)","author":"Lundh","year":"2025","journal-title":"OSF"},{"key":"10.1016\/j.jclinepi.2026.112415_bib26","article-title":"Influence and management of conflicts of interest in randomised clinical trials: qualitative interview study","volume":"371","author":"\u00d8stengaard","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2026.112415_bib27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jclinepi.2023.06.020","article-title":"A structured approach to information retrieval improved identification of funding and researchers\u2019 conflicts of interest in trials included in Cochrane reviews","volume":"161","author":"Faltinsen","year":"2023","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2026.112415_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinepi.2025.112003","article-title":"User experience of Tool for Addressing Conflicts of Interest in Trials (TACIT) prototype: interview and questionnaire study","volume":"188","author":"Faltinsen","year":"2025","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2026.112415_bib29","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.5","article-title":"Chapter 7: Considering bias and conflicts of interest among the included studies","author":"Boutron","year":"2024"},{"key":"10.1016\/j.jclinepi.2026.112415_bib30","author":"Lundh"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089543562600291X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089543562600291X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:47:05Z","timestamp":1788983225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089543562600291X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":28,"alternative-id":["S089543562600291X"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2026.112415","relation":{},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The importance of adequate user feedback for developing appraisal tools for evidence synthesis\u2013the case of TACIT (Tool for Addressing Conflicts of Interest in Trials)","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinepi.2026.112415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112415"}}